AI-generated summary
The authors report a narrative review of about 60 selected articles on photobiomodulation therapy (PBMT) and its possible anti-inflammatory role in acute respiratory distress syndrome linked to COVID-19. They describe PBMT as non-invasive and safe, and suggest it could reduce viral load and control inflammation. These conclusions are proposals drawn from the reviewed literature rather than confirmed clinical effects.
- Studies included
- 60
- Who or what was studied
- Patients with COVID-19 and acute respiratory distress syndrome, with supporting evidence drawn from studies on PBMT in inflammation.
- Limits stated in the abstract
- The abstract describes a review of selected articles with no stated pooled outcome data, and its suggestions about viral load and prevention are not supported by stated clinical results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Low-level laser therapy, Photobiomodulation, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.